Oct 2026· Brain : a journal of neurology· 0 citations
Medicine
TL;DR
It is demonstrated that the long non-coding RNA Malat1 acts as a critical endothelial regulator of angiogenesis and neurological restoration and establishes the Malat1-Tek axis as a novel signaling pathway essential for driving post-ischemic cerebrovascular remodeling and long-term functional recovery.
Abstract
Ischemic stroke remains a leading cause of mortality and disability worldwide, yet current therapeutic strategies, such as thrombolysis and thrombectomy, are constrained by narrow treatment windows and incomplete microvascular repair. While angiogenesis is pivotal for long-term functional recovery, the epigenetic mechanisms governing post-stroke vascular remodeling remain poorly understood. Here, we demonstrate that the long non-coding RNA (lncRNA) Malat1 acts as a critical endothelial regulator of angiogenesis and neurological restoration. Using an endothelium-specific Malat1 overexpression mouse model (EC-Malat1 Tg), we demonstrate endothelial Malat1 upregulation enhances angiogenesis, restores cerebral blood flow, and improves sensorimotor and cognitive function following ischemic stroke. Mechanistically, fluorescence-activated cell sorting (FACS)-based RNA sequencing of brain endothelial cells identified novel downstream targets of Malat1, including Hapln2, Bcl6, Esr1, Sox17, Tfrc, Hsp90aa1, and Tek. Among these, Tek (Tie2) showed robust endothelial co-localization and direct interaction with Malat1. Notably, while Malat1 overexpression markedly increased Tek protein expression, adeno-associated virus (AAV)-mediated endothelial knockdown of Tek abrogated the pro-angiogenic and neurovascular reparative effects of Malat1. Collectively, our data establishes the Malat1-Tek axis as a novel signaling pathway essential for driving post-ischemic cerebrovascular remodeling and long-term functional recovery. Targeting Malat1 represents a novel restorative therapeutic approach for ischemic stroke.
The results show that andrographolide promotes post-stroke vascular repair, at least in part, by regulating the interaction between brain immune cells and vascular cells, offering new insight into how this compound may support brain repair after ischemic stroke.
Hong-Fei Li, Hai-Rong Xiang, Xin-Yu Li et al.· Biology· 0 citations
Background:
Therapeutic angiogenesis remains an attractive strategy for Ischemic heart disease (IHD), yet clinical translation has been limited by the inability to generate durable and functional vascular networks. Increasing evidence suggests that successful vascular repair depends not only on endothelial activatio...
Ya-Jing Qiu, Sheng-Yi Zhou, Fen Liu et al.· Circulation· 0 citations
NGR1 alleviates ischemic neuronal injury, at least in part, by interfering with CKLF1/CCR5-associated signaling, thereby attenuating pathological metabolic reprogramming, neuroinflammation, and apoptosis.
Han-Long Wang, Sha-Sha Liu, Chen Chen et al.· Frontiers in Pharmacology· 0 citations
CD147 exacerbates ischemic brain injury and BBB disruption by suppressing neuronal Wnt/β-catenin signaling through a mechanism involving the AKT/GSK3β node, supporting further evaluation of CD147-directed interventions after stroke.
Yue-Qing Wang, F. Ogunleye, Chong-Lin Xu et al.· Scientific Reports· 0 citations
Large-vessel recanalization is essential in acute ischemic stroke, but it does not guarantee microvascular reperfusion. Endothelial responses may contribute to persistent tissue hypoperfusion through leukocyte trafficking and immunothrombosis. Many of these responses may begin during ischemia and may continue or intens...
Li Gao, Zi-Xuan Liang, Jian-Qin Xie· Frontiers in Immunology· 0 citations
TAAL negatively regulated TIE1 protein levels via ubiquitin-mediated degradation without altering TIE1 mRNA expression, and its function was conserved in zebrafish, where taal knockdown produced angiogenic defects rescued by human TAAL.